| 11. |
|
|
| 12. |
|
|
| 13. |
|
|
| 14. |
- Mellin, Pelle, et al.
(author)
-
Detecting argon trapped in reference samples made by hot isostatic pressing
- 2016
-
In: World PM 2016 Congress and Exhibition. - : European Powder Metallurgy Association (EPMA). - 9781899072484
-
Conference paper (peer-reviewed)abstract
- We reveal in this paper a procedure to make reference materials containing a known level of Ar. Risk assessment when detecting Ar in a production material is based on the content relative to a specified safety limit (usually 50 ngAr/gsteel). Hence we only need to know if a production material contains more or less than this limit. Now, we can produce material at this limit. To evaluate, we use two types of instruments, on the following contents: 24, 48, 71, 95 and ngAr/gsteel. We found that all instruments could distinguish a higher and a lower level, from the safety limit. These contents are close to the lowest detectable limit for both instruments. The instruments are a G8 Galileo from Bruker Elemental and an ELTRA-Werf (several units) from Takon AB. The mechanisms of Argon segregation are reflected upon as the need for a uniform distribution in reference samples is important. Especially if one would do the instrument calibration solely based on reference samples in the future.
|
|
| 15. |
- O'Byrne, P. M., et al.
(author)
-
Measuring asthma control: a comparison of three classification systems
- 2010
-
In: European Respiratory Journal. - : European Respiratory Society (ERS). - 1399-3003 .- 0903-1936. ; 36:2, s. 269-276
-
Journal article (peer-reviewed)abstract
- There are various ways to classify asthma control; however, no classification is universally accepted. This retrospective analysis compared asthma control as assessed by the Asthma Control Questionnaire (5-item version; ACQ-5), Global Initiative for Asthma (GINA) or Gaining Optimal Asthma Control (GOAL) study criteria. Pooled data at the final study week (n=8,188) from three budesonide/formoterol maintenance and reliever therapy studies which measured ACQ-5 were stratified according to GINA or GOAL criteria and ACQ-5 score distribution. The percentages of patients with a controlled/partly controlled week (GINA), totally/well-controlled week (GOAL) and range of ACQ-5 cut-off points were compared. Patients with GINA controlled, partly controlled and uncontrolled asthma had mean ACQ-5 scores of 0.43, 0.75 and 1.62, respectively. Patients with GOAL totally controlled, well-controlled and uncontrolled asthma had ACQ-5 scores of 0.39, 0.78 and 1.63. The kappa measure of agreement was 0.80 for GINA and GOAL criteria, and 0.63 for GINA controlled/partly controlled and ACQ-5 <1.00. ACQ-5 detected clinically important improvements in 49% of patients who, according to GINA criteria, remained uncontrolled at the end of the study. Asthma control measured by GINA or GOAL criteria provides similar results. GINA Controlled/Partly Controlled and GOAL Totally Controlled/Well-Controlled correspond to ACQ-5 <1.00. The ACQ-5 is more responsive to change in a clinical trial setting than a categorical scale.
|
|
| 16. |
|
|
| 17. |
|
|
| 18. |
- Ostlund, O., et al.
(author)
-
Radiation efficiency of partially coherent electromagnetic beams
- 2001
-
In: Journal of the Optical Society of America A. - 0740-3232. ; 18:7, s. 1696-1703
-
Journal article (peer-reviewed)abstract
- We present a general definition of the radiation efficiency of stationary electromagnetic fields and prove that it is bounded between zero and unity for beams of any state of coherence and polarization. The radiation efficiency may be interpreted as a measure of how directed the radiated fields are, and therefore it can be used to assess the allowed spatial coherence and intensity variations across a beam. We consider a class of partially coherent electromagnetic fields that were recently introduced in the literature and evaluate the radiation efficiencies for two particular examples, namely, the azimuthally polarized symmetric beams and the dipolar beams that are nearly linearly polarized in the central region. The results show that the radiation efficiency is fairly insensitive to the state of polarization and that it differs appreciably from unity for only small values of source and correlation widths.
|
|
| 19. |
|
|
| 20. |
- Reddel, H. K., et al.
(author)
-
Effect of different asthma treatments on risk of cold-related exacerbations
- 2011
-
In: European Respiratory Journal. - : European Respiratory Society (ERS). - 1399-3003 .- 0903-1936. ; 38:3, s. 584-593
-
Journal article (peer-reviewed)abstract
- Common colds often trigger asthma exacerbations. The present study compared cold-related severe exacerbations during budesonide/formoterol maintenance and reliever therapy, and different regimens of maintenance inhaled corticosteroids (ICS), with or without long-acting beta(2)-agonists (LABA), and with as-needed short-acting beta(2)-agonists (SABA) or LABA. Reported colds and severe exacerbations (defined by oral corticosteroid use and/or hospitalisation/emergency room visit) were assessed for 12,507 patients during 6-12 months of double-blind treatment. Exacerbations occurring <= 14 days after onset of reported colds were analysed by a Poisson model. The incidence of colds was similar across treatments. Asthma symptoms and reliever use increased during colds. Budesonide/formoterol maintenance and reliever therapy reduced severe cold-related exacerbations by 36% versus pooled comparators plus SABA (rate ratio (RR) 0.64; p=0.002), and for individual treatment comparisons, by 52% versus the same maintenance dose of ICS/LABA (RR 0.48; p < 0.001); there were nonsignificant reductions versus higher maintenance doses of ICS or ICS/LABA (RR 0.83 and 0.72, respectively). As-needed LABA did not reduce cold-related exacerbations versus as-needed SABA (RR 0.96). Severe cold-related exacerbations were reduced by budesonide/formoterol maintenance and reliever therapy compared with ICS with or without LABA and with as-needed SABA. Subanalyses suggested the importance of the ICS component in reducing cold-related exacerbations. Future studies should document the cause of exacerbations, in order to allow identification of different treatment effects.
|
|
